Status:
UNKNOWN
Intra Uterine Growth Restriction
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Intrauterine Growth Restriction
Eligibility:
All Genders
Brief Summary
Intrauterine growth restriction (IUGR) is associated with an increase in perinatal mortality and morbidity, as well as longer-term neurological, cognitive, cardiovascular and endocrine complications. ...
Eligibility Criteria
Inclusion
- All birth more than 24 + 0 weeks of amenorrhea at the maternity ward of the hospital Femme-Mère-Enfant
- from 1st of january 2011 to 31 december 2017.
Exclusion
- Infants born out of the hospital and secondarily hospitalized in the hospital Femme-Mère-Enfant .
- Multiple pregnancies,
- children with congenital fetal anomalies
- pregnancies without first trimester ultrasound (to date the pregnancy)
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
31052 Patients enrolled
Trial Details
Trial ID
NCT03866863
Start Date
September 1 2018
End Date
April 1 2019
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Femme Mère Enfant
Bron, France